http://www.unboundmedicine.com/medline/ebm/research/cyclophosphamideUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19927363/full_citation/Immunoadsorption_apheresis_and_immunosuppressive_drug_therapy_in_the_treatment_of_complicated_HCV_related_cryoglobulinemia_Stefanutti C, Vivenzio A, Di Giacomo S, et al. 
Immunoadsorption apheresis and immunosuppressive drug therapy in the treatment of complicated HCV-related cryoglobulinemia. [JOURNAL ARTICLE]
J Clin Apher 2009 Nov 19.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19926952/full_citation/[A_case_of_primary_testicular_malignant_lymphoma_associated_with_contralateral_testicural_recurrence_after_a_nine_year_interval:_a_case_report_]Maruyama T, Hashimoto T, Suzuki T, et al. 
[A case of primary testicular malignant lymphoma associated with contralateral testicural recurrence after a nine-year interval: a case report.] [JOURNAL ARTICLE]
Hinyokika Kiyo 2009 Oct; 55(10):639-643.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19926148/full_citation/VNCOP_B_plus_rituximab_therapy_in_elderly_patients_with_aggressive_B_cell_non_Hodgkin_lymphoma:_A_multicenter_experience_Ishii K, Urase F, Nagare Y, et al. 
VNCOP-B plus rituximab therapy in elderly patients with aggressive B-cell non-Hodgkin lymphoma: A multicenter experience. [JOURNAL ARTICLE]
Arch Gerontol Geriatr 2009 Nov 17.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19925877/full_citation/Nonmyeloablative_HLA_Haploidentical_BMT_with_High_Dose_Posttransplantation_Cyclophosphamide:_Effect_of_HLA_Disparity_on_Outcome_Kasamon YL, Luznik L, Leffell MS, et al. 
Nonmyeloablative HLA-Haploidentical BMT with High-Dose Posttransplantation Cyclophosphamide: Effect of HLA Disparity on Outcome. [JOURNAL ARTICLE]
Biol Blood Marrow Transplant 2009 Nov 16.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19925857/full_citation/Comet_assay_in_murine_bone_marrow_cell_line__FDC_P2__Oshida K, Iwanaga E, Miyamoto K, et al. 
Comet assay in murine bone-marrow cell line (FDC-P2). [JOURNAL ARTICLE]
Toxicol In Vitro 2009 Nov 16.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19922532/full_citation/Pulsed_Intravenous_Cyclophosphamide_and_Methylprednisolone_Therapy_in_Refractory_Pemphigus_Saha M, Powell AM, Bhogal B, et al. 
Pulsed Intravenous Cyclophosphamide and Methylprednisolone Therapy in Refractory Pemphigus. [JOURNAL ARTICLE]
Br J Dermatol 2009 Nov 18.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19922500/full_citation/Variable_effects_of_cyclophosphamide_in_rodent_models_of_experimental_allergic_encephalomyelitis_Mangano K, Nicoletti A, Patti F, et al. 
Variable effects of cyclophosphamide in rodent models of experimental allergic encephalomyelitis. [JOURNAL ARTICLE]
Clin Exp Immunol 2009 Nov 18.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19921987/full_citation/Early_high_dose_immunosuppression_in_Henoch_Schönlein_nephrotic_syndrome_may_improve_outcome_Andersen RF, Rubak S, Jespersen B, et al. 
Early high-dose immunosuppression in Henoch-Schönlein nephrotic syndrome may improve outcome. [JOURNAL ARTICLE]
Scand J Urol Nephrol 2009; 43(5):409-415.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19921311/full_citation/Primary_cardiac_lymphoma:_diagnostic_tools_and_treatment_challenges_Bambury R, Gallagher F, Dodd JD, et al. 
Primary cardiac lymphoma: diagnostic tools and treatment challenges. [JOURNAL ARTICLE]
Ir J Med Sci 2009 Nov 17.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19921192/full_citation/Clinical_efficacy_of_a_bortezomib_cyclophosphamide_thalidomide_and_dexamethasone__Vel_CTD__regimen_in_patients_with_relapsed_or_refractory_multiple_myeloma:_a_phase_II_study_Kim YK, Sohn SK, Lee JH, et al. 
Clinical efficacy of a bortezomib, cyclophosphamide, thalidomide, and dexamethasone (Vel-CTD) regimen in patients with relapsed or refractory multiple myeloma: a phase II study. [JOURNAL ARTICLE]
Ann Hematol 2009 Nov 18.
Abstract | Full Citation | Find Related Articles